Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 3;22(1):198.
doi: 10.1186/s12933-023-01924-2.

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk

Affiliations

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk

Xiao-Ling Cai et al. Cardiovasc Diabetol. .

Abstract

Background: Early identification of populations at high cardiovascular disease (CVD) risk and improvement of risk factors can significantly decrease the probability of CVD development and improve outcomes. Insulin resistance (IR) is a CVD risk factor. The triglyceride glucose (TyG) index is a simple and reliable index for evaluating IR. However, no clinical studies on the prognostic value of the TyG index in a high risk CVD population have been conducted. This study evaluated the relationship between the TyG index and prognosis in a high risk CVD population.

Methods: This study enrolled 35,455 participants aged 35-75 years who were at high CVD risk and visited selected health centers and community service centers between 2017 and 2021. Their general clinical characteristics and baseline blood biochemical indicators were recorded. The TyG index was calculated as ln[fasting triglyceride (mg/dl)× fasting blood glucose (mg/dl)/2]. The endpoints were all-cause death and cardiovascular death during follow-up. Cox proportional hazard models and restricted cubic spline (RCS) analysis were used to evaluate the correlation between the TyG index and endpoints.

Results: In the overall study population, the mean age of all participants was 57.9 ± 9.6 years, 40.7% were male, and the mean TyG index was 8.9 ± 0.6. All participants were divided into two groups based on the results of the RCS analysis, with a cut-off value of 9.83. There were 551 all-cause deaths and 180 cardiovascular deaths during a median follow-up time of 3.4 years. In the multivariate Cox proportional hazard model, participants with a TyG index ≥ 9.83 had a higher risk of all-cause death (Hazard ratio [HR] 1.86, 95% Confdence intervals [CI] 1.37-2.51, P<0.001) and cardiovascular death (HR 2.41, 95%CI 1.47-3.96, P = 0.001) than those with a TyG index < 9.83. Subgroup analysis revealed that there was no interaction between the TyG index and variables in all subgroup analyses.

Conclusions: The high TyG index was associated with an increased risk of all-cause death and cardiovascular death in people at high risk of CVD. This finding demonstrates the value of the TyG index in the primary prevention of CVD.

Trial registration: retrospectively registered, the registration number is K2022-01-005 and the date is 2022.01.30.

Keywords: High risk cardiovascular disease patients; Prognosis; Triglyceride glucose index.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of population selection in this study
Fig. 2
Fig. 2
Hazard ratios for A All-cause death and B cardiovascular death based on restricted cubic spines for the TyG index. Red lines represented references for hazard ratios, and red areas represent 95% confdence intervals
Fig. 3
Fig. 3
Kaplan–Meier analysis of A All-cause death and B cardiovascular death in various TyG groups
Fig. 4
Fig. 4
Forest plot of all-cause death according to diferent subgroups. Subgroup analysis included age (< 60 years vs. ≥ 60 years), gender (male vs. female), current smoking status (Yes vs. No), diabetes status (Yes vs. No), and BMI (< 25 kg/m2 vs.≥ 25 kg/m2)

References

    1. Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. doi: 10.1186/s12933-022-01546-0. - DOI - PMC - PubMed
    1. Roth GA, Mensah GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risks: a compass for global action. J Am Coll Cardiol. 2020;76(25):2980–1. doi: 10.1016/j.jacc.2020.11.021. - DOI - PubMed
    1. Li X, Wu C, Lu J, et al. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5(12):e672–81. doi: 10.1016/S2468-2667(20)30191-2. - DOI - PubMed
    1. Lindh M, Banefelt J, Fox KM, et al. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from swedish population-based register data. Eur Heart J Qual Care Clin Outcomes. 2019;5(3):225–32. doi: 10.1093/ehjqcco/qcy058. - DOI - PMC - PubMed
    1. Toth PP, Danese M, Villa G, et al. Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. J Med Econ. 2017;20(6):555–64. doi: 10.1080/13696998.2017.1284078. - DOI - PubMed

Publication types

LinkOut - more resources